ONCOLOGY

Fibrinolysis and Thrombolysis

Jan 1, 2019 by in ONCOLOGY Comments Off on Fibrinolysis and Thrombolysis

SUMMARY Print Section Listen SUMMARY Improved understanding of the molecular mechanisms of fibrinolysis has led to major advances in fibrinolytic and antifibrinolytic therapy. Characterization of the genes for all the…

read more

The Antiphospholipid Syndrome

Jan 1, 2019 by in ONCOLOGY Comments Off on The Antiphospholipid Syndrome

SUMMARY Print Section Listen SUMMARY The antiphospholipid (aPL) syndrome (APS) is an acquired thrombophilic disorder in which patients have vascular thrombosis and/or pregnancy complications attributable to placental insufficiency, accompanied by…

read more

Thrombotic Microangiopathies

Jan 1, 2019 by in ONCOLOGY Comments Off on Thrombotic Microangiopathies

SUMMARY Print Section Listen SUMMARY Thrombotic microangiopathy is a general term for the combination of micro­angiopathic hemolytic anemia and thrombocytopenia, often accompanied by signs and symptoms consistent with disseminated microvascular…

read more

von Willebrand Disease

Jan 1, 2019 by in ONCOLOGY Comments Off on von Willebrand Disease

SUMMARY Print Section Listen SUMMARY von Willebrand factor (VWF) is a central component of hemostasis, serving both as an adhesive link between platelets and the injured blood vessel wall and…

read more

Hereditary Thrombophilia

Jan 1, 2019 by in ONCOLOGY Comments Off on Hereditary Thrombophilia

SUMMARY Print Section Listen SUMMARY Thrombophilia refers to laboratory abnormalities that increase the risk of venous thromboembolism (VTE). Over the past several decades, numerous factors have been identified. The most…

read more

Platelet Morphology, Biochemistry, and Function

Jan 1, 2019 by in ONCOLOGY Comments Off on Platelet Morphology, Biochemistry, and Function

SUMMARY Print Section Listen SUMMARY The approximately 1 trillion platelets that circulate in an adult human are small anucleate cell fragments adapted to adhere to damaged blood vessels, to aggregate…

read more

Antibody-Mediated Coagulation Factor Deficiencies

Jan 1, 2019 by in ONCOLOGY Comments Off on Antibody-Mediated Coagulation Factor Deficiencies

SUMMARY Print Section Listen SUMMARY Clinically significant autoantibodies to coagulation factor deficiencies are uncommon but can produce life-threatening bleeding and death. The most commonly targeted coagulation factor in autoimmunity is…

read more

Hereditary Fibrinogen Abnormalities

Jan 1, 2019 by in ONCOLOGY Comments Off on Hereditary Fibrinogen Abnormalities

NOTE Print Section Listen The authors thank Dr. Alessandro Casini for helpful comments and suggestions. SUMMARY Print Section Listen SUMMARY Hereditary fibrinogen abnormalities make up two classes of plasma fibrinogen…

read more
Get Clinical Tree app for offline access